Table 1 Patient characteristics.
Characteristics | |
|---|---|
Total patients | 299 |
Median age at surgery (range), y | 67 (46–77) |
Median PSA (range), ng/mL | 7.6 (2.3–87.16) |
PI-RADS v2.0 score, n (%) | |
1–2/3/4/5 | 66 (22.1%)/25 (8.4%)/138 (46.2%)/70 (23.4%) |
PI-RADS v2.1 score, n (%) | |
1–2/3/4/5 | 35 (11.7%)/56 (18.7%)/138 (46.2%)/70 (23.4%) |
Radiological location (TZ/PZ) | 107/192 |
Surgical approach n (%) | |
Open/laparoscopic/robot-assisted | 33 (11.0%)/76 (25.4%)/190 (63.5%) |
Lymph node dissection, n (%) | 234 (78.3%) |
Pathological Grade Group, n (%) | |
1/2/3/4/5 | 23 (7.7%)/123 (41.1%)/93 (31.1%)/24 (8.0%)/35 (11.7%) |
Undiagnosed | 1 (0.3%) |
Extraprostatic extension (EPE1), n (%) | 71 (23.7%) |
Resection margin (RM+), n (%) | 89 (29.8%) |
Seminal vesicle invasion (SV+), n (%) | 28 (9.4%) |
Lymph node metastasis (N1), n (%) | 4 (1.3%) |
Median observation period (months) | 49.8 |
Biochemical failure, n (%) | 48 (16.1%) |